Metformin Sr Flamingo

Metformin Hydrochloride, the active ingredient in Metformin Sr Flamingo, is a biguanide presented as an oral tablet for systemic use. It is indicated for the management of type 2 diabetes mellitus in adult patients, helping to improve glycemic control when used as part of a comprehensive diabetes treatment plan that includes diet and exercise.

GNH USA supplies Metformin Sr Flamingo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring product quality and regulatory compliance across multiple markets.

Metformin Sr Flamingo is a biguanide used in the treatment of disorders related to impaired glucose metabolism. - Type 2 diabetes mellitus (adults): lowers fasting and post‑prandial blood glucose levels. - Type 2 diabetes mellitus combined with lifestyle modification: enhances overall glycemic control when used with diet and exercise. - Type 2 diabetes mellitus inadequately controlled on monotherapy: can be added to other antidiabetic agents to achieve target HbA1c.

Metformin may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: frequent loose stools, especially during dose titration. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic failure: impaired liver function leading to accumulation of drug. - Hypoglycemia: uncommon when used alone, may occur with other agents. - Vitamin B12 deficiency: long‑term therapy can reduce absorption. - Pancreatitis: very rare inflammation of the pancreas.

Metformin should be used with careful clinical assessment and monitoring. - Renal function: assess eGFR before initiation and periodically thereafter. - Hepatic disease: avoid in patients with severe liver impairment. - Cardiovascular status: monitor for signs of heart failure, especially in the elderly. - Alcohol consumption: limit intake to reduce risk of lactic acidosis. - Pregnancy and lactation: consider only if potential benefit justifies potential risk. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metformin may interact with several medicines, requiring dose adjustment or monitoring.

Major Interactions (Avoid): - Iodinated contrast agents: increase risk of acute renal failure and lactic acidosis. - Cimetidine: can raise plasma metformin concentrations. - Alcohol: potentiates lactic acidosis risk.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycemia. - Diuretics (especially thiazides): affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and electrolytes.